NCT06267144 2024-02-20
Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer
The First Hospital of Jilin University
Unknown
Clinical Trials
5 trialsNCT04513301 2020-08-14
Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study
Shanghai Cancer Hospital, China
Phase 2 Unknown
NCT04486287 2020-07-24
Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer
Tianjin Medical University Second Hospital
Phase 2 Unknown
NCT04189094 2019-12-06
Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT03765775 2018-12-06
Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative
First Hospital of Shijiazhuang City
Phase 2 Unknown